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The molecular process underlying T cell anergy is
incompletely understood. Deltex1 (DTX1) is a Notch
target with unknown physiological function. Here
we show that Dtx1 was a transcription target of
nuclear factor of activated T cells (NFAT) and partic-
ipated in T cell anergy. DTX1 protein was upregulated
during T cell anergy, and transgenic expression of
Dtx1 attenuated T cell activation. DTX1 inhibited
T cell activation by both E3-dependent and E3-inde-
pendent mechanisms. In addition, DTX1 suppressed
T cell activation in the absence of its Notch-binding
domain. Importantly, DTX1 regulated the expression
of two anergy-associated molecules, growth arrest
and DNA-damage-inducible 45 b (Gadd45b) and
Cbl-b. DTX1 interacted with early growth response
2 (Egr-2) for optimum expression of Cbl-b. Further-
more, deficiency of DTX1 augmented T cell activa-
tion, conferred resistance to anergy induction,
enhanced autoantibody generation, and increased
inflammation. DTX1 therefore represents a compo-
nent downstream of calcium-NFAT signaling that
regulates T cell anergy.
INTRODUCTION
T cell anergy is generated in vivo by stimulation of T cell recep-
tors in the absence of any costimulatory molecule (Schwartz,
2003; Fathman and Lineberry, 2007; Saibil et al., 2007). The
partial activation of T cells that follows, with new protein
synthesis, leads to a state unresponsive to further stimulation
through the antigen receptor. T cell anergy can also be produced
in vitro by treating T cells with a calcium ionophore alone or
through the activation of nuclear factor of activated T cells
(NFAT) (Macia´n et al., 2002). Recent studies have revealed the
involvement of specific E3 ubiquitin ligases, including Cbl-b,
Itch, and the gene related to anergy in lymphocyte (GRAIL, ring
finger protein 128 [Rnf128]), in T cell anergy (Anandasabapathy
et al., 2003; Heissmeyer et al., 2004; Gao et al., 2004; Jeon
et al., 2004; Fathman and Lineberry, 2007). T cell anergy is
also mediated by molecules and processes independent of E3,72 Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc.such as LAT palmitoylation, p27Kip1, and diacylglycerol kinase-a
(Hundt et al., 2006; Li et al., 2006; Zha et al., 2006; Olenchock
et al., 2006). In addition, a number of genes, including growth
arrest and DNA-damage-inducible 45 b (Gadd45b), early growth
response gene 2 (Egr2) and Egr3, are upregulated in anergic
T cells (Safford et al., 2005). Interestingly, Cbl-b, Itch, GRAIL,
Egr-2, Egr-3, and diacylglycerol kinase-a are downstream
targets of calcium-NFAT signaling (Heissmeyer et al., 2004;
Zha et al., 2006). Egr-2 and Egr-3 have been shown to regulate
the expression of Cbl-b by a mechanism yet to be characterized
(Safford et al., 2005).
Deltex was originally identified in Drosophilia by its genetic
interaction with Notch (Matsuno et al., 1995) and is a gene trans-
activated by Notch (Matsuno et al., 1998). Deltex (DTX) contains
two WWE domains at its N terminus, which account for its inter-
action with Notch (Zweifel et al., 2005), followed by a proline-rich
motif and a RING finger domain at the C terminus. Several
studies suggest that Deltex plays a critical role in the RBP-J-
independent Notch signaling pathway (Ramain et al., 2001;
Hu et al., 2003; Hori et al., 2004). Recent generation of a Dtx null
mutant in Drosophila, however, suggests that Deltex is involved
only in a fraction of Notch signaling that is RBP-J dependent
(Fuwa et al., 2006). The function of Deltex in Notch signaling
transduction in mammals remains mostly ambiguous. Overex-
pression of DTX1 also inhibits Notch signals, as shown by
enhanced B cell lymphocyte development and suppressed
T cell development (Izon et al., 2002; Yun and Bevan, 2003).
We recently demonstrated that overexpression of DTX1
suppresses T cell activation, whereas Dtx1 downregulation
enhances T cell activation (Liu and Lai, 2005). We found that,
as an E3 ligase, DTX1 binds MAP kinase/ERK kinase kinase 1
(MEKK1) and stimulates its ubiquitination and degradation (Liu
and Lai, 2005). However, lymphocyte development and antibody
production are normal in mice with a DTX1 mutant lacking the
RING finger domain (Storck et al., 2005), suggesting that E3
ligase activity of DTX1 is not absolutely required for lymphocyte
development and function. In a second DTX1 gene-targeted
study, deletion of the first WWE domain did not affect lympho-
cyte and myeloid cell development (Lehar and Bevan, 2006).
The phenotypes found in these two Dtx1D/D mice are in sharp
contrast to the profound effect of Notch deficiency in lympho-
cyte differentiation (Radtke et al., 2004; Maillard et al., 2005;
Tanigaki and Honjo, 2007; Rothenberg et al., 2008). Because
the Deltex family contains four members (DTX1, DTX2, DTX3,
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Deltex1 Regulates T Cell AnergyFigure 1. Upregulation of DTX1 in T Cell Anergy Induced by Calcium Ionophore and CTLA4-Fc
(A and B) A23817-triggered T cell anergy. T cells from AND transgenic mice were primed to Th1 cells, and then treated with indicated doses of A23187 for 16 hr.
T cells were washed and restimulated with the specific antigen pigeon cytochrome c (PCC) and irradiated presenting cells. T cell proliferation (A) was determined
by 3H-thymidine incorporation 60 hr later, whereas IL-2 production (B) was quantified after 24 hr.
(C and D) T cell anergy induced by CTLA4-Fc. AND Th1 cells were stimulated by antigen and irradiated presenting cells in the absence or presence of CTLA4-Fc
for 2 days. T cells were isolated and T cell proliferation (C) and IL-2 generation (D) were determined during restimulation with PCC-presenting cells.
(E and G) DTX1 was upregulated in anergic T cells triggered by A23187 or CTLA4-Fc. Lysates from T cells tolerized by A23187 or CTLA4-Fc were analyzed for
expression of ZAP70, PKCq, DTX1, and MEKK1 via immunoblots.
(F and H) Induction of Dtx1 transcript in T cells tolerized by A23187 and CTLA4-Fc. The expression of Dtx1 mRNA was determined 16 hr after A23187 (F) or 36 hr
after CTLA4-Fc cotreatment (H) of AND T cells.
Values (A–D) are the mean ± SD of triplicate samples. Data shown are the representative of two independent experiments.and DTX4) in mammals (Kishi et al., 2001; Storck et al., 2005), the
lack of effect from targeting Dtx1 could be due to compensation
from other Deltex members for the physiological function of
DTX1. Alternatively, either the RING finger or the WWE domain
may be dispensable for the function of DTX1 in lymphocyte
development.
In the present study, we generated DTX1-deficient mice
without resorting to truncated Dtx1 transcripts. We identified
that DTX1 is an important player in T cell anergy: DTX1 is induced
in T cell anergy, and Dtx1 is a transcription target of NFAT. We
showed that DTX1 suppressed T cell activation by both ubiquitin
E3-dependent and E3-independent mechanisms. DTX1 also
controlled the expression of Gadd45b and Cbl-b. Deletion of
Dtx1 promoted T cell activation, conferred resistance to toler-
ance induction, and led to increased inflammation and autoim-
munity. Our results identify DTX1 as an NFAT target that
promotes T cell anergy.
RESULTS
Dtx1 Is Upregulated in Anergic T Cells
We found that T cell anergy is associated with increased DTX1
expression. Anergy was induced in AN6.2 and 5C.C7-derivedTCR (AND) Th1 cells by persistent calcium signaling (A23187
treatment) in the absence of other stimulation (Macian et al.,
2002) or by blockage of costimulatory signaling via cytotoxic T
lymphocyte antigen-4 (CTLA4)-Fc (Wells et al., 2001). The status
of anergy was confirmed by attenuated T cell proliferation and
diminished IL-2 production when stimulated by the specific
antigen pigeon cytochrome c (PCC) (Figures 1A–1D), with the
extent of anergy proportional to the concentration of A23187
used. Similar to previous observations in anergic T cells (Heiss-
meyer et al., 2004), A23187 or CTLA4-Fc treatment led to
decreased PKCq expression (Figures 1E and 1G). In addition,
there was a prominent induction of DTX1 protein (Figures 1E
and 1G). The upregulation of DTX1 in anergic T cells was accom-
panied with a proportional downregulation of MEKK1(C) (Figures
1E and 1G), the catalytically active form of MEKK1 (Liu and Lai,
2005). In contrast, expression of ZAP70 was not substantially
altered in anergic T cells (Figures 1E and 1G), as reported by
Jeon et al. (2004) and Hundt et al. (2006). T cell anergy was
also induced in vivo in mice by intravenous administration of
anti-CD3, as shown by the attenuated T cell responses upon re-
stimulation (Figures S1A and S1B available online). In anti-CD3-
triggered T cell anergy, there was also a profound induction of
DTX1 protein, with nearly undetectable MEKK1(C) (Figure S1C).Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc. 73
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Deltex1 Regulates T Cell AnergyThe extent of DTX1 induction was proportional to the dose of
A23187 used to tolerize T cells (Figure 1E). The increase in DTX1
protein correlated with an upregulation of Dtx1 mRNA in anergic
T cells (Figures 1F and 1H). The increase in DTX1 transcript and
protein was also proportional to the duration of A23187 stimula-
tion (Figures S2A and S2B). Abolition of calcium ionophore-
mediated signaling by cyclosporin-A, previously shown to
prevent T cell anergy, suppressed the induction of Dtx1 mRNA
and DTX1 protein by A23187 (Figures S2C and S2D). Therefore,
expression of DTX1 is strongly associated with T cell anergy.
Dtx1 Is a Transcription Target of NFAT
Because Dtx1 is induced in anergic T cells (Figures 1F and 1H)
and NFAT dictates the expression of several T cell anergy-asso-
ciated molecules (Macia´n et al., 2002; Heissmeyer et al., 2004),
we went on to examine whether Dtx1 expression is linked to
NFAT. There is an NFAT-like binding sequence (GGAAAA)
88 bp upstream of the AUG site in the Dtx1 promoter. Overex-
pression of NFATc and NFATp in T cells enhanced the expression
of Dtx1 mRNA and protein (Figures 2A and 2B), suggesting that
Dtx1 is a transcription target of NFATc and NFATp. This was
further confirmed by the activation of the Dtx1 promoter (1300
to1 bp) in T cells treated with A23187 or transfected with NFATc
or NFATp (Figures 2C and 2D). A DNA affinity precipitation assay
(DAPA) also illustrated that nuclear-localized NFATp and NFATc
(Figures 2E and 2F, Input) were brought down by biotinylated
NFAT-containing sequence from the Dtx1 promoter in A23187-
treated EL4 cells (Figures 2E and 2F, DAPA). The association of
NFAT with Dtx1 promoter in vivo was further examined by chro-
matin immunoprecipitation (ChIP) analysis. Anti-NFATp or anti-
NFATc, but not mouse IgG control, pulled down DNA containing
the NFAT-binding element on theDtx1 promoter (Figures 2G and
2H), indicating that NFAT is bound to the promoter ofDtx1 in aner-
gic T cells. Therefore,Dtx1 is a direct transcription target of NFAT.
Transgenic Expression of Dtx1 Suppresses T Cell
Activation
To further delineate the role of DTX1 in T cell anergy in vivo,Dtx1-
transgenic mice were generated with a Cd4 promoter to direct
T cell-specific Dtx1 expression (Figure S3A). Dtx1 transgene
expression in T cells led to a reduction in MEKK1 expression,
but did not interfere with T cell profiles in thymocytes and sple-
nocytes (Figures S3B and S3C). A profound suppression of the
proliferation and IL-2 production of thymocytes (Figures S3D
and S3F) and splenic T cells (Figures S3E and S3G) from Dtx1-
transgenic mice was found, compared to those of normal litter-
mate controls (NLC) mice. Neither the CD44loCD62Lhi naive
T cell fraction nor the CD44hiCD62Llo memory T cell population
was affected by the DTX1 transgene (Figures S3H and S3I).
Overexpression of DTX1 did not affect the CD4+CD25+ popula-
tion, Foxp3 expression in CD4+CD25+ or CD4+CD25 cells
(Figure S3J), or production of IL-10 and TGF-b by regulatory T
(Treg) cells (Figures S3K and S3L). Therefore, transgenic DTX1
inhibits T cell activation but does not alter T cell development.
DTX1 Also Inhibits T Cell Activation through
an E3-Independent Mechanism
Two independent Dtx1 gene-targeted mice have recently been
generated, with no apparent immunological phenotype de-74 Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc.tected. Deletion of the RING finger domain from DTX1 did not
affect either lymphocyte development or T cell-dependent B
cell responses (Storck et al., 2005), whereas the removal of the
first WWE domain from DTX1 (Supplemental Results, Figure S4)
did not interfere with normal lymphocyte development (Lehar
and Bevan, 2006).
We therefore examined the ability of DTX1 lacking either the
RING finger domain (DTX1DRF) or the WWE domain (DTX1DN)
to suppress T cell activation. In contrast to wild-type DTX1,
Figure 2. DTX1 Is a Target of NFAT
(A and B) Dtx1 is a transcription target of NFAT. DO11.10 T cell hybridomas
were transfected with pcDNA3 vector, NFATc, or NFATp, and the expression
of Dtx1 transcripts (A) and DTX1 protein (B) was determined 24 hr later.
(C) Activation of Dtx1 promoter by A23187. Luciferase reporter driven by Dtx1
promoter (1300 to1 bp) (Dtx1-Luc) was transfected into EL4 cells, and lucif-
erase activity stimulated by A23187 or DMSO was determined after 24 hr.
(D) Direct activation of the Dtx1 promoter by NFATc or NFATp. EL4 cells were
transfected with Dtx1-Luc plus pcDNA3, NFATc, or NFATp, and luciferase
quantified after 24 hr.
(E and F) Association of NFAT withDtx1 promoter sequences. Nuclear extracts
were prepared in DO11.10 cells treated with DMSO () or A23187 for 1 hr (E)
and 3 hr (F). Biotinylated oligonucleotides corresponding to NFAT element on
Dtx1 promoter were used in DNA affinity precipitation assay (DAPA). The
precipitates were resolved by SDS-PAGE and probed with anti-NFATp (E) or
anti-NFATc (F).
(G and H) Localization of NFATp or NFATc on Dtx1 promoter. DO11.10 cells
were treated with DMSO () or A23187 for 1 hr (G) and 3 hr (H), cross-linked
with formaldehyde, and nuclei isolated. Fragmented chromatin was immuno-
precipitated with anti-NFATp (4G6-G5), anti-NFATc (7A6), or control mouse
IgG. The presence of NFAT-element-containing Dtx1 promoter region was
identified by PCR. Inputs are the PCR products from fragmented chromatins.
Values (C, D) are the mean ± SD of triplicate samples. Data shown are the
representative of two independent experiments.
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Deltex1 Regulates T Cell AnergyFigure 3. DTX1 Inhibits T Cell Activation also through E3- and WWE-Independent Mechanism
(A) RING finger (RF) domain deletion abolished the ability of DTX1 to downregulate MEKK1. DO11.10 cells were transduced with control retrovirus (YFP) or retro-
virus containing either DTX1-Myc or DTX1DRF-Myc. The infected cells were sorted and the expression of DTX1-Myc, DTX1DRF-Myc, and MEKK1 was deter-
mined by anti-Myc. FL, full length MEKK1; C, C-terminal domain of MEKK1.
(B) RING finger domain deletion from DTX1 (DTX1DRF) led to a partial decrease in the inhibition of T cell activation. YFP-, DTX1-, or DTX1DRF-expressing
DO11.10 T cells were stimulated with anti-CD3+anti-CD28 at the indicated concentrations, and IL-2 produced was quantified.
(C and D) DTX1DRF inhibited JNK, but not p38 MAPK. YFP control and DO11.10 cells expressing DTX1 or DTX1DRF were activated and total cell extracts
prepared at the indicated time points. The activation of JNK was assessed with anti-phospho JNK (T183-Y185) and anti-JNK1 (C), whereas the activation of
p38 MAPK was determined by anti-phospho p38 MAPK (T180-Y182) and anti-p38a (D).
(E) DTX1 mutants lacking WWE domain or with additional inactivated RF domain still inhibited T cell activation. YFP control and DO11.10 cells expressing DTX1,
WWE domain-deleted DTX1 (DTX1DN), and DTX1 double mutant (DTX1DN-H2N2) were activated through TCR+CD28 stimulation, and IL-2 expression was
determined.
(F and G) DTX1, DTX1DRF, DTX1DN, or DTX1DN-H2N2 promoted the expression ofGadd45b in T cells. DO11.10 T cells were transduced with YFP vector, DTX1,
DTX1DRF, DTX1DN, or DTX1DN-H2N2 and total RNA (F) or total cell lysates (G) were prepared. The expression of Gadd45b transcript (F) was determined by
RT-PCR. The expression of Gadd45b protein and various DTX1 constructs (G) were quantified by anti-Gadd45b and anti-Myc, respectively.
(H) DTX1 and its mutants activateGadd45b promoter. TheGadd45b promoter (1191 to +140) was subcloned into pGL3 and transfected into EL4 cells with DTX1,
DTX1DRF, DTX1DN, DTX1DN-H2N2, or NF-kB p65 at the indicated doses (in mg) by electroporation. Luciferase activity was determined after another 24 hr.
Values (B, E, H) are the mean ± SD of triplicate samples. Data shown are the representative of two (A, C, D, F, G), three (E, H), or four (B) independent experiments.DTX1DRF did not affect MEKK1 expression (Figure 3A). The
removal of the RING finger domain modestly reduced the ability
of DTX1 to attenuate T cell activation (Figure 3B), supporting
a contribution of the E3 ligase activityof DTX1 toT cell inactivation.
However, DTX1DRF still effectively suppressed T cell activation
(Figure 3B), indicating that DTX1 also inhibits T cell activation in
an E3-independent manner. In addition, DTX1DRF inhibited JNK
activation in the presence of intact MEKK1 (Figure 3C). RING
finger deletion did abolish the ability of DTX1 to suppress TCR-
mediated p38 MAPK activation (Figure 3D). Therefore, both the
E3 activity and RF-independent activities of DTX1 contribute toits inhibition of T cell activation. A similar observation was found
for DTX1 lacking the WWE domain (DTX1DN), which produced
an attenuated, but still effective, suppression of T cell activation
(Figure 3E). Though less effective than DTX1, DTX1DN inhibited
the activation of JNK and p38 MAPK (Figures S5A and S5B). In
addition, the DTX1 double mutant (DTX1DN-H2N2) with inactive
RF and deleted WWE still inhibited T cell activation (Figure 3E).
The DTX1 double mutant did not inhibit p38 MAPK, but modestly
antagonized the activation of JNK and ERK (Figures S6A–S6C),
suggesting that DTX1 may antagonize activation signals in the
absence of E3 ligase and Notch-binding abilities.Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc. 75
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Deltex1 Regulates T Cell AnergyWe further identified another suppressive mechanism
whereby DTX1 blocks JNK activation. Overexpression of DTX1
in T cells led to expression of Gadd45b mRNA and Gadd45b
protein (Figures 3F and 3G). Gadd45b is known to suppress
JNK by inactivation of MKK7 (Papa et al., 2007), suggesting
that DTX1 could inhibit JNK activation by transactivation of
Gadd45b. DTX1DRF, DTX1DN, or DTX1DN-H2N2 induced
Gadd45b transcript and protein expression to an extent compa-
rable to the wild-type DTX1 (Figures 3F and 3G). We isolated the
Gadd45b promoter (1191 bp to +140 bp) and demonstrated
that DTX1 alone, similar to NF-kB p65 (De Smaele et al., 2001),
activated the Gadd45b promoter (Figure 3H). Inactivation of
the RF domain, WWE domain, or both domains did not affect
the ability of DTX1 to activate theGadd45b promoter (Figure 3H).
Together, DTX1 inhibits T cell activation also in E3- and Notch-
binding-independent manners, with induction of Gadd45b as
one of such mechanisms.
DTX1 Deficiency Does Not Affect T Cell Development
The observation that DTX1 may inhibit T cell activation in the
absence of RF or WWE domains led us to produce a new line
of DTX1 gene-targeted mice completely lacking the Dtx1 tran-
script. A loxP-flanked (fl) Dtx1 locus was generated by inserting
a neomycin cassette (Neo) into intron 3 and lox P sites into
introns 2 and 3 (Figure 4A). Exon 3 and Neo were systematically
deleted by breeding Dtx1fl/+ mice with EIIa-Cre transgenic mice,
followed by intercrossing between F1 progeny. Deletion of Dtx1
was confirmed by Southern blot analysis (Figure 4B). The ab-
sence of Dtx1-truncated coding transcripts was also confirmed
with primers to detect exons 2–3, exons 8–10, and 30-UTR of
Dtx1 in RT-PCR analyses (Figure 4C). Deletion of the exon 3
did not affect the expression of exons 1–2 of Dtx1. DTX1 protein
was also undetectable in splenic lymphocytes by immunoblot
analysis (Figure 4D). These results indicate that our Dtx1-tar-
geted mutant was indeed a Dtx1 null mouse line. We also
produced Dtx1fl/flDneo mice with only Neo deleted by breeding
Dtx1fl/fl mice with ACT-FLPe transgenic mice.
Dtx1/ mice were viable and fertile. DTX1 deficiency did not
apparently interfere with thymocyte development or bone
marrow B cell development (Figures 4E and 4F), similar to mice
with genetic deletion of either RING-finger or WWE domains
from Dtx1 (Storck et al., 2005; Lehar and Bevan, 2006). The total
thymocyte and bone marrow cell numbers were comparable
between control and Dtx1/ mice (Figure S7A). Early T cell
development and differentiation of gd T cells were indistinguish-
able between normal and Dtx1/ mice (Figure S7B). Popula-
tions of mature CD4+ and CD8+ T cells were similar between
normal and Dtx1/ mice (Figures S7C and S7D). DTX1 defi-
ciency also did not alter the CD4+CD25+ population, the
CD4+Foxp3+ population, or Foxp3 expression in CD4+CD25+
and CD4+CD25 cells (Figures S8A–S8C). The production of
inhibitory cytokines by Treg cells was mostly not affected by
DTX1 deficiency except for a moderate decrease of TGF-
b (Figures S8D and S8E). A more detailed description of B cells
in Dtx1/ mice is described in Supplemental Results (Figures
S9 and S10). Therefore, the majority of the lymphocyte popula-
tions we examined were not substantially affected by the
absence of DTX1, suggesting that DTX1 is mostly dispensable
for lymphocyte development. DTX1 deficiency did lead to76 Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc.increased MEKK1 expression and reduced Gadd45b expression
(Figure S7E).
Increased T Cell Activation and Systemic Inflammation
Diseases in Dtx1/ Mice
Despite the relatively normal lymphocyte population, there was
an increase in total mature peripheral lymphocyte numbers in
8-week-old Dtx1/ mice (Figure 5A). Modest splenomegaly
was always detected in Dtx1/ mice (Figure 5A). The increase
in total mature lymphocytes may be due to a reduced suscepti-
bility of thymocytes to spontaneous T cell death (Figure S11).
DTX1 deficiency led to a profound increase in T cell activation.
The proliferation of Dtx1/ thymocytes and splenic T cells
doubled relative to those of NLC T cells, as measured by
3H-thymidine incorporation (Figure 5B). Increased proliferation
in DTX1 null T cells was also confirmed by CFSE halving (Fig-
ure S12). TCR-induced IL-2 production was similarly elevated
in Dtx1/ splenic T cells (Figure 5C). Production of IFN-g and
IL-4 increased by nearly 100% in DTX1-deficient T cells (Figures
5D and 5E). We also characterized the signaling abnormality in
DTX1-deficient T cells. Activation of JNK, p38 MAPK, and ERK
was prominently increased in Dtx1/ T cells (Figures 5F–5H).
As a control, T cell activation was not affected in Dtx1fl/flDneo
mice (Figure S13).
We went on to investigate whether elevated activation of T cells
was linked to T cells themselves or was due to accessory cells.
We generated mice with T cell-specific deletion of Dtx1 (CD4-
Dtx1/). The absence of DTX1 in splenic T cells was confirmed
by immunoblots (not shown). T cell proliferation and IL-2 produc-
tion were substantially higher for CD4-Dtx1/ T cells than for
control T cells (Figure S14). The increase in T cell activation was
comparable between T cells from Dtx1/ mice and T cells from
CD4-Dtx1/ mice, suggesting that the observed elevated T cell
activation was chiefly due to DTX1 deficiency in T lymphocytes.
The deletion of theDtx1 gene altered the sensitivity of T cells to
anergy induction. In T cell anergy triggered by calcium ionophore
(Figure 6A) or CTLA4-Fc (Figure 6B), DTX1 deficiency decreased
the extent of T cell tolerance, as measured by IL-2 production
(Figures 6A and 6B), or T cell proliferation (not shown). The
IC50 for A23187 to induce anergy was increased from 75 ng/ml
in WT cells to 360 ng/ml in DTX1 null T cells (Figure 6C). A similar
increase in IC50 in DTX1-deficient T cells was also found with
CTLA4-Fc (Figure 6D). Dtx1/ T cells were more resistant to
anergy induction than T cells from control littermates.
We also found that deletion of the Dtx1 gene increased the
susceptibility of mice to autoimmune disease. Hematoxylin and
eosin (H&E) staining of paraffin-embedded sections of lung
and liver revealed mononuclear cell infiltrations in older DTX1-
deficient mice (>9 months) (Figure 6E), in contrast to control
littermates. Anti-DNA and anti-histone in the serum of Dtx1/
mice were elevated (Figures 6F and 6G), predominantly of IgM
and IgG2b isotypes (Figure S15). A modest increase in autoanti-
body titer was also found in CD4-Dtx1/ mice (Figure S16), sup-
porting the role of T cell in autoimmunity. There was no apparent
abnormality in the morphology of kidney glomeruli of Dtx1/
mice, yet immunoglobulin complex was detected in the kidney
glomeruli of Dtx1/ mice (Figure 6H). Taken together, these
disparate findings suggest that DTX1 deficiency in T cells led
to increased inflammation and autoimmunity.
Immunity
Deltex1 Regulates T Cell AnergyFigure 4. Targeted Disruption of Dtx1
(A) Structure of Dtx1 genome and targeting construct. Upper panel (Dtx1 WT) illustrates the genomic structure of Dtx1. The exons are numbered according to
NCBI. The targeting construct is illustrated in the second panel, with genomic fragments corresponding to short arm (P to X) and long arm (B to N) indicated.
The null allele is illustrated at bottom. B, BamHI; Bg, BglII; N, NheI; P, PmlI; Sc, ScaI; X, XmnI.
(B) Homologous recombination of the targeting construct and Cre recombination of the floxed allele. Left panels show Southern analysis of ScaI- or BglII-digested
genomic DNA from wild-type and targeted R1 ES clones by probe 1 or 2 (indicated in A), respectively. Right panel shows Southern analysis of ScaI-digested
genomic DNA from wild-type (+/+), +/, and null (/) mice by probe 1.
(C) Absence of Dtx1 transcript expression in Dtx1/ mice. RNA isolated from splenocytes of control and Dtx1/ mice was subjected to RT-PCR analysis with
primers flanking exons 1–2, intron 2, exons 2–3, exons 8–10, or 30-untranslated region. Primers for intron 2 were to screen hidden miRNA in that region.
(D) Absence of DTX1 protein in Dtx1/ mice. Expression of DTX1 protein in Dtx1/ and WT littermate in splenic lymphocytes was determined by immunoblot.
(E) Normal thymocyte development in DTX1-deficient mouse. Thymocytes from WT littermate and Dtx1/ mice were stained with anti-CD4 and anti-CD8 to
assess different thymocyte populations. n = 8.
(F) Normal bone marrow B cell development in DTX1-deficient mice. Bone marrow cells were stained with anti-IgM and anti-B220 to analyze the
populations of developing B lymphocytes. imB, immature B; Pre+Pro, PreB plus ProB. n = 5. Number (E, F) indicates percentage and standard deviation of
each subpopulation.DTX1 Interacts with Egr-2 for Optimal Cbl-b Expression
The availability of a DTX1-deficient T cell enabled us to search for
additional signaling defects caused by DTX1 deficiency. We
examined the induction of Cblb, Itch, Dgka, Rnf128, Egr2, Egr3,
and Gadd45b in T anergy generated by A23187 (Figure 7A).
The expression of most anergy-associated molecules was not
affected by the absence of DTX1, yet Ca2+-mediated upregula-tion of Cbl-b and Gadd45b mRNA and protein were largely abol-
ished in Dtx1/ T cells (Figures 7A and 7B). The impaired induc-
tion of Cbl-b and Gadd45b in Dtx1/ T cells was also found in
T cell anergy generated through costimulatory blockade
(Figure S17). Because Cbl-b expression is mediated by Egr-2
and Egr-3 (Safford et al., 2005), we examined whether DTX1
modulates the transactivation of Cbl-b by Egr-2. OverexpressionImmunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc. 77
Immunity
Deltex1 Regulates T Cell AnergyFigure 5. Enhanced Activation and Increased Cytokine Production in DTX1-Deficient T Cells
(A) Moderate splenomegaly in Dtx1/ mice. The total splenocyte numbers for six pairs of Dtx1/ and WT littermate mice were compared. Spleens from a pair of
Dtx1/ and WT control are shown (right).
(B and C) Enhanced T cell activation in Dtx1/ mice. Thymocytes and splenic T cells from Dtx1/ mice and WT littermates were stimulated with the indicated
amount of anti-CD3+anti-CD28, and T cell proliferation (B) or splenic T cell IL-2 production (C) were determined 50 hr (B) or 24 hr (C) later.
(D and E) Both IFN-g and IL-4 production were increased in Dtx1/ T cells. IFN-g production was measured in splenic T cells at same time as IL-2 in (C). For IL-4
production, splenic T cells were first activated with TPA (10 ng/ml) and A23187 (80 ng/ml) for 1 day, washed, and cultured with IL-2 for 2 additional days. T cells
were restimulated with anti-CD3+anti-CD28, and IL-4 generated quantitated 24 hr later.
(F–H) Increased MAPK activation in DTX1-deficient T cells. Phosphorylation of JNK (F), p38 MAPK (G), and ERK (H) in splenic T cells after anti-CD3+anti-CD28
(5 mg/ml and 2.5 mg/ml) stimulation was determined.
Values (B–E) are the mean ± SD of triplicate samples. Data shown are the representative of three (F–H) or five (B–E) independent experiments.of DTX1 alone in T cells did not induce the expression of Cbl-b, in
contrast to a clear stimulatory effect of Egr-2 (Figures 7C and 7D).
However, addition of DTX1 increased Egr-2-stimulated Cbl-b
expression. The enhancement of Egr-2-mediated Cbl-b expres-
sion did not apparently involve the WWE or RF domains of DTX1:
DTX1DN, DTX1DRF, and DTX1DN-H2N2 were as effective as
DTX1 in promoting the expression of Cbl-b (Figure 7E). The
synergistic effect of Egr-2 and DTX1 on Cbl-b expression was
also observed on T cell activation. T cell activation was substan-
tially attenuated by expression of either DTX1 or Egr-2, yet was
nearly shut down by the simultaneous presence of DTX1 and
Egr-2 (Figure 7F). In addition, there was an interaction between
DTX1 and Egr-2-FLAG, demonstrated by the fact that DTX1
was pulled down by FLAG antibodies (Figure 7G). Therefore,
Cbl-b is another anergy-associated molecule that is directly
regulated by DTX1 through partnership with Egr-2.78 Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc.DISCUSSION
Notch is well known for its pivotal role in dictating lymphocyte
development (Radtke et al., 2004; Maillard et al., 2005; Tanigaki
and Honjo, 2007; Rothenberg et al., 2008). Notch signaling is
essential for T cell fate specification. Many Notch-mediated
T cell development events are mediated by RBP-J (Tanigaki
and Honjo, 2007). In contrast, a role for DTX in Notch signaling
in T cell development has yet to be demonstrated. Two Dtx1
gene targeting studies have illustrated that the RING finger
domain or WWE domains of DTX1 are dispensable for normal
lymphocyte development (Storck et al., 2005; Lehar and Bevan,
2006). Consistent with their finding, T cell development was
nearly normal in our Dtx1/ mice. Therefore, contrary to the
profound effect of Notch1 absence in T cell development,
DTX1 deficiency does not apparently affect T cell development.
Immunity
Deltex1 Regulates T Cell AnergyFigure 6. Deficiency in DTX1 Impairs T Cell Anergy Generation and Leads to Inflammation and Autoimmunity
(A–D) Absence of DTX1 impaired the induction of T cell anergy. Splenic T cells from WT littermate and Dtx1/ mice were primed to Th1 and treated with A23187
for 16 hr (A) or CTLA4-Fc (B) to induce anergy. T cells were then stimulated with anti-CD3+anti-CD28 and IL-2 expression was determined after another 24 hr, and
the shown results are the mean ± SD of triplicate samples from a single experiment (A, B). IL-2 production in the absence of anergy induction was used as 100%
and the percentages of attenuation by treatment with A23187 (C) and CTLA4-Fc (D) shown are the mean ± SD from 3 independent experiments.
(E) Inflammation in DTX1-deficient mouse. Lung and liver from 9-month-old Dtx1/ mice and normal littermate controls (WT) were embedded in paraffin,
sectioned, and stained with hematoxylin and eosin (H&E). Scale bars represent 100 mm in lung sections and 200 mm in liver sections.
(F and G) Serum anti-DNA and anti-histone antibodies in Dtx1/ mice. Sera (1:100 dilution) from Dtx1/ mice and WT littermates older than 5 months were
analyzed for anti-DNA and anti-histone antibodies. n = 6.
(H) Immunoglobulin deposits in kidney glomeruli in Dtx1/ mice. Kidney frozen sections from Dtx1/ mice and WT littermates were stained with Alexa Fluor
488-anti-mouse IgM or FITC-anti-mouse IgG. Scale bars represent 50 mm. The morphology of glomeruli was examined by H&E staining.
Micrographs (E, H) shown are the representative of five pairs of mice.The lack of effect on T cell development by Dtx1/ may be due
to the presence of DTX2, DTX3, and DTX4, the three other DTX
family members. Alternatively, enhanced Notch signaling is
detected with deficiencies of DTX (Lehar and Bevan, 2006), sug-
gesting that DTX1 does not mediate, but instead blocks, Notch1
signaling. We found that DTX1 deficiency led to increased IL-4
production in peripheral T cells, in direct contrast to the direct
activation of IL-4 expression by Notch (Tanaka et al., 2006;
Fang et al., 2007), suggesting that DTX1 may act in opposition
to Notch. Additionally, given the complexity of Notch signaling,
DTX1 may mediate Notch2 signals and inhibit Notch1 signaling.
More work is required to establish the exact role of the DTX
family in Notch signaling in T cells.
We had previously illustrated that DTX1 is an ubiquitin E3 ligase
that directs MEKK1(C) for degradation (Liu and Lai, 2005). In this
study we further found that DTX1 suppresses T cell activation,
also in an E3-ligase-independent manner. Removal of the RF
domain impaired the ability of DTX1 to suppress p38 MAPK,but DTX1 retained a partial capacity to attenuate T cell activation.
We identified two additional mechanisms that DTX1 used to
inhibit T cell activation, neither of which required the RF domain.
First, DTX1 inhibits JNK activation through enhanced expression
of Gadd45b. Gadd45b suppresses JNK signaling (De Smaele
et al., 2001) by direct binding to MKK7 (Papa et al., 2007). The
induction of Gadd45b is specifically relevant to anergy, as indi-
cated by the fact that it is overexpressed in anergic T cells (Saf-
ford et al., 2005) and Gadd45b deficiency leads to autoimmunity
(Liu et al., 2005). Identification of Gadd45b as a DTX1 target also
illustrates the double-action of DTX1 to attenuate JNK activation
by downregulation of MEKK1 and stimulation of GADD45b
expression. There are similarities and differences in phenotype
between theDtx1/ mouse and theGadd45b/ mouse. Hyper-
proliferation is observed in both Gadd45b/ T cells (Liu et al.,
2005) and Dtx1/ T cells. Splenomegaly and IgM deposition in
glomeruli are found in both Gadd45b/ (Liu et al., 2005) and
Dtx1/ mice. Alternatively, TCR-induced IFN-g production isImmunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc. 79
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Deltex1 Regulates T Cell AnergyFigure 7. DTX1 Coordinates with Egr-2 for Cbl-b Expression
(A and B) Diminished expression of Cbl-b and Gadd45b in Dtx1/ Th1 cells during anergy induction. T cells from control (WT) and Dtx1/ mice and were primed
to Th1 cells and were treated with A23187 (200 ng/ml) for 4, 8, 12 (A), or 16 (B) hr.
(A) RNA was isolated and the expression of Cblb, Itch, Dgka, Rnf128, Egr2, Egr3, Gadd45b, and Actb determined by RT-PCR.
(B) Cell lysates were prepared and the expression of Cbl-b, Itch, Gadd45b, DTX1, and b-tubulin analyzed by immunoblot.
(C and D) Egr-2-stimulated Cbl-b expression was enhanced by DTX1. DO11.10 T cells were transfected with DTX1-Myc and Egr-2-FLAG as indicated, and the
expression of the mRNA (C) and protein (D) of Cbl-b and Itch determined.
(E) WWE or RF domains were not required for DTX1 to enhance Egr-2-mediated Cbl-b expression. DO11.10 cells expression YFP (Control), DTX1, DTX1DN,
DTX1DRF, or DTX1DN-H2N2 were transfected with Egr-2 (+) or vector (), and the expression of Cbl-b determined.
(F) Synergistic inhibitory effect of DTX1 and Egr-2 on T cell activation. DO11.10 T cells, transfected with the indicated constructs, were stimulated with anti-
CD3+anti-CD28 24 hr after transfection. IL-2 was quantitated 18 hr after activation. Values are the mean ± SD of triplicate samples.
(G) Interaction between Egr-2 and DTX1. DTX1-Myc and Egr-2-FLAG were transfected into Jurkat cells, and cell lysates were prepared 24 hr later. Samples of
200 mg of cell lysates were precipitated with anti-FLAG, and DTX1-Myc was detected by anti-Myc by immunoblot. The expression of DTX1-Myc, Egr-2, and
GAPDH in cell lysates was also determined.
Data (A–G) shown are the representative of two independent experiments.impaired inGadd45b/ T cells (Lu et al., 2004) but is enhanced in
Dtx1/ T cells. TCR-mediated activation of ERK and p38 MAPK
is reduced inGadd45b/ T cells (Lu et al., 2004) but is increased
in Dtx1/ T cells. The difference between Gadd45b null and
DTX1 null mice can be partly attributed to the fact that DTX1
deficiency decreases, but does not completely abolish, the
expression of Gadd45b. Furthermore, DTX1 regulates additional
anergy-contributing molecules.
The second identified mechanism DTX1 uses to promote T cell
anergy is the DTX1-dependent expression of Cbl-b. DTX1 defi-
ciency diminished expression of Cbl-b in anergic T cells. We
showed here that DTX1, similar to Egr-2 and Egr-3, is a down-
stream target of NFAT that regulates the transcription of Cblb.
The regulatory effect of DTX1 is Cbl-b specific, as shown by
the fact that Itch and GRAIL remained unaffected in DTX1-defi-
cient T cells. DTX1 alone did not promote the expression of
Cbl-b, yet DTX1 augmented Egr-2-mediated Cbl-b expression.
Dtx1/ and Cblb/ mice share some phenotype similarities.80 Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc.T cell proliferation and IL-2 production are profoundly increased
in Dtx1- and Cblb-deficient T lymphocytes (Chiang et al., 2000;
Bachmaier et al., 2000). The susceptibility of Cblb/ mice to
acute lung inflammation (Bachmaier et al., 2007) may be
analogous to the lung inflammation we observed in Dtx1/
mice. However, there are also clear differences between
Cblb/ and Dtx1/ T cells. The activation of JNK, ERK, and
p38 MAPK is not affected in Cblb/ T lymphocytes (Bachmaier
et al., 2000), but was prominently enhanced in Dtx1/ T cells.
The production of IFN-g in the primary stimulation of T cell is
not altered in Cblb/ T cells (Bachmaier et al., 2000), but here
was elevated in Dtx1/ T cells. Therefore, DTX1 regulates the
amount of MEKK1, Gadd45b, and Cbl-b, yet the function of
DTX1 cannot be attributed to any one of MEKK1, Gadd45b, or
Cbl-b.
Another notable observation is this study is that the inhibitory
activity of DTX1 on T cell activation was only weakly compro-
mised in the absence of the WWE domain. Notch binding
Immunity
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T cell signaling. DTX1DN stimulates Gadd45b expression, indis-
tinguishably from DTX1 and DTX1DRF. In addition, DTX1 lacking
the WWE domain, similar to DTX1DRF, enhanced Cbl-b expres-
sion. The observation that DTX1 controls the expression of
Gadd45b and Cbl-b in the absence of WWE or RF domains
demonstrates the diversified action mechanism of DTX1 in aner-
gic T cells. There is a discrepancy between our DTX1 null mice
and the previous two DTX1 gene-targeted mice (Storck et al.,
2005; Lehar and Bevan, 2006): whereas inflammation and auto-
immunity were detected in the present study, no apparent
abnormality in lymphocyte function was found in the previous
two DTX1 gene-targeted mice. We speculate that expression
of the truncated DTX1 with deletion of either RING finger domain
or WWE domains in these two gene-targeted mice still
suppresses T cell activation. It may also be noted that we found
autoimmune pathology in relatively old (>9-month-old) Dtx1/
mice. Given the moderate effect of DTX1DN or DTX1DRF on
T cell activation, some manifestation of autoimmunity at later
stages cannot be excluded for the previous two DTX1 gene-
targeted mice.
It may also be noted that in addition to a prominent role in T cell
anergy, DTX1 is involved in the attenuation of B cell activation.
The contribution of B cells to some of the autoimmune pheno-
types in Dtx1/ mice therefore cannot be excluded. We did
not detect any change of Treg cell populations in Dtx1-trans-
genic and Dtx1/ mice, but found a modest decrease of TGF-b
production in Dtx1/ Treg cells, suggesting that a role of Treg
cells in T cell suppression cannot be completely ruled out. Future
experiments shall help map the exact contribution of DTX1 from
each cell population to prevent autoimmunity.
In summary, DTX1 is an addition to the list of molecules that
contribute to T cell tolerance. Dtx1 is a transcription target of
NFAT that contributes to T cell anergy. NFAT binds to Dtx1
promoter and promotes the expression of DTX1. It has previ-
ously been noted that T cell anergy is attained by the coordinated
action of a complicated array of molecules (Saibil et al., 2007). Of
the several E3 ligases that contribute to T cell anergy, each acts
with a distinct mechanism: Cbl-b targets Vav-1, GRAIL binds
RhoGDI, Itch promotes the degradation of JunB, and DTX1 stim-
ulates the ubiquitination of MEKK1(C). Interestingly, similar to
other tolerance-associated E3 ligases, DTX1 is localized in endo-
somes (Hori et al., 2004; Mukherjee et al., 2005). How the endo-
cytic vesicle localization links to the action of DTX1 is currently
being investigated. Among the E3 ligases associated with
T cell anergy, DTX1 is unique in its ability to block T cell activation
in both E3-dependent and E3-independent manners. Impor-
tantly, the identification of Gadd45b and Cbl-b as targets of
DTX1 reveals a network in the regulation of T cell anergy by
Ca2+-NFAT signaling. Ca2+-NFAT signaling stimulates the
expression of DTX1, Egr-2, and Egr-3, and DTX1 in turn coordi-
nates with Egr-2 and Egr-3 for the induction of Cbl-b. Whereas
NFAT separately promotes the expression of Itch and GRAIL,
the anergic function of NFAT is further extended by DTX1
through Gadd45b expression and MEKK1 downregulation. In
addition, MEKK1, GADD45b, and Cbl-b are likely not the sole
mediators of DTX1 in T cell anergy: DTX1DN is as effective as
DTX1 in stimulating Gadd45b and Cbl-b expression, and
DTX1DN downregulates MEKK1 via an intact RF domain, yetDTX1DN was less inhibitory than DTX1, indicating the presence
of an additional suppressive mechanism of DTX1 that is WWE
dependent. Moreover, DTX2, DTX3, and DTX4 may also regulate
T cell tolerance, so the contribution from the whole DTX family to
T cell anergy is likely higher than that which we report in the
present study. Further work will help establish the full role of
DTX family members in T cell anergy.
EXPERIMENTAL PROCEDURES
Reagents
Mouse Dtx1 cDNA (Kishi et al., 2001) was a gift from H. Okano (Keiko Univer-
sity, Tokyo). DTX1DRF was generated by deletion of the C-terminal amino
acids 347–627 from DTX1 (full-length 1–627 aa) by BamHI cleavage. DTX1DN
was generated by deletion of the first 179 amino acid (containing both WWE
domains) from DTX1 via PCR. The double mutant DTX1DN-H2N2 was gener-
ated from DTX1DN by inactivation of RF through mutation of H453 and H456
into N453 and N456. DTX1DRF, DTX1DN, and DTX1DN-H2N2 were subcloned
into pcDNA4 and pGC-YFP for expression in T cells. The Dtx1 promoter
(1300 bp to 1 bp) and Gadd45b promoter (1191 to +140 bp) were isolated
by PCR and subcloned into pGL2 and pGL3 luciferase reporter vector, respec-
tively.
T Cell Anergy Induction
CD4+CD25 T cells isolated from spleen were primed into Th1 cells as
described in Supplemental Experimental Procedures. For anergy generated
by CTLA4-Fc, T cells (2 3 105 per well) and g-irradiated presenting cells (8 3
105 per well) were treated with anti-CD3 (5 mg/ml) and CTLA4-Fc for 2 days,
washed, and restimulated with specific antigen or anti-CD3/anti-CD28.
Production of Dtx1-Transgenic Mice
Dtx1 was subcloned into Cd4 promoter, a gift from D.R. Littman (New York
University School of Medicine, NY). Transgenic mice were generated in the
Transgene-Knockout Core of the Institute of Molecular Biology, Academia Sin-
ica (Taipei, Taiwan). CD4-Dtx1 was microinjected into the pronuclei of C57BL/
6 zygotes. All transgenic mice were maintained in the SPF mice facility of the
Institute of Molecular Biology, Academia Sinica. All mouse experiments were
conducted with approval from the Experimental Animal Committee, Academia
Sinica.
Production of Dtx1/ Mice
The targeting construct was designed to delete exon 3 of Dtx1. A neomycin
cassette with FLPe recombinase recognition sequence (Frt) at both ends
was inserted into intron 3 of Dtx1. Two lox P sites were inserted into intron
2 and intron 3 so that exon 3 and Neo were flanked (fl) by lox P. The PmlI-
XmnI fragment of intron 2 (1783 bp) was used as the short arm and Herpes
simplex virus thymidine kinase (TK) gene was introduced into its 50 end
(Figure 4A). The BamHI-NheI fragment (6445 bp) of intron 3 was used as the
long arm (Figure 4A). The construct was electroporated into R1 ES cells and
G418- and gancyclovir-resistant clones were first screened by PCR. Only
one positive clone was identified out of 1515 picked clones. The positive clone
was confirmed by Southern blot analysis (Figure 4B) and was then injected into
mouse blastocytes to generate chimera. Three mice with chimerism of 95%
were then bred with C57BL/6 mice to confirm germline transmission, and
the Dtx1fl/+ mice were maintained by breeding with C57BL/6 mice. EIIa-Cre
(B6.FVB-Tg(EIIa-Cre)C5379Lmgd/J) and ACT-FLPe (B6.Cg-Tg(ACTFLPe)
9205Dym/J) transgenic mice were obtained from the Jackson Laboratory
(Bar Harbor, ME). Cd4-Cre mice were obtained from Taconic Farms (Hudson,
NY). Dtx1fl/+ mice were crossed with EIIa-Cre mice for systemic deletion of
Dtx1 (Dtx1fl/+EIIa-Cre) and then intercrossed to generate mice with homozy-
gous deletion of Dtx1 (Dtx1fl/flEIIa-Cre, abbreviated as Dtx1/). Dtx1/
mice were backcrossed with C57BL/6 mice for 5 or more generations
for this study. Dtx1fl/flDneo mice were obtained by breeding Dtx1fl/fl with
ACT-FLPe mice to delete Neo. Dtx1fl/flDneo mice were then crossed with
Cd4-Cre for T cell-specific deletion of Dtx1 (Dtx1fl/flCd4-Cre, abbreviated as
CD4-Dtx1/).Immunity 31, 72–83, July 17, 2009 ª2009 Elsevier Inc. 81
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